All GLG News Analyses Filed Under: Business of Medicine

FDA has been lax for years in cGMP inspections of all foreign drug and drug-intermediate suppliers, China included. Nothing is done by FDA until a tragedy occurs. Scientific Protein Laboratories did not provide quality oversight to its Chinese porcine intestine suppliers nor have adequate QC analytical...

Pharma recommends more drug than may actually be needed. This does not apply just to Cerezyme, but the Epo products (Amgen & J&J), Avastin (Genentech.)

Prison terms to be handed out for fraud by a health care financing firm. Go figure?

One of the biggest reasons why IT adoption is still languishing so far behind in health care is that the return on investment at least for physicians in the near term is so tenuous.  Consequently, physicians expect the federal government to be making a much bigger financial commitment than...

The financial responsibity will lie with Baxter, not the FDA.  Perhaps moral or political responsibility (and fall out) will rest with the FDA, but that is of no help to those harmed by the Heparin.  Their only recourse is to sue the manufacturer.

I haven't been following siRNA closely but let me offer some specific areas of concern and some perspective that may help you find higher-confidence  conclusions. One concern with RNA approaches has been specificity. Cells can respond to unusual RNA with a non-specific interferon...

A entirely new concept in curing incurable diseases, such as Huntington's Disease and MS is beginning to show Proof of Concept.  The next several years will witness an exponential rise in research in this arena, as biotechs such as Alnylam (ALNY) and ISIS (ISIS) demonstrate the feasibility of this...

Manufacturers include Roche Holding AG and Novartis AG of Switzerland and Sanofi-Aventis. Generic versions of the antineoplastic agents will be made available and the patents obviously ignored.

The new President of the Joint Commission, Mark Chassin, M.D., has only been on the job for a couple of months, but he is already moving quickly to effect big changes not only at the Joint Commission, but in the entire $2.3 trillion healthcare industry. Long baffled by the myriad of data systems...

Why is the Jarvik ad campaign any more offensive than the famous line quoted above? If any direct-to-consumer (DTC) advertising is acceptable, then why is there any furor over the use of actors who are not technically qualified as pitchmen?